Na, Corrected
normal ranges: 133-148 mEq/L
The Revised Cardiac Risk Index estimates the likelihood of major cardiac complications after noncardiac surgery.
Indikationen
Used to estimate ≥1% perioperative MACE risk in adults undergoing elective, urgent, or time‑sensitive non‑cardiac surgery, guiding need for further evaluation per ACC/AHA guidelines 1 [Level I evidence]. Best for mixed non‑cardiac procedures; performance is modest (AUC ~0.75) and poor in vascular surgery 2 [Level II evidence]. Helps identify low-risk patients who can proceed without additional cardiac testing.
Hinweise & Vorsichtsmaßnahmen
Underestimates risk in vascular and valvular disease and has modest discrimination (AUC ~0.75 in pooled validation) 1 [Level II evidence]. Misses stroke, major bleeding, prolonged stay, ICU need, and noncardiac factors. Recent 2022–2024 guidelines caution against relying on any single tool and note inconsistent calibration across populations 1 [Level I evidence]. Use only as a screen, not as a standalone decision‑maker.